GKB Ophthalmics Ltd

GKB Ophthalmics, a microcap company in the FMCG industry, reported a flat performance in the quarter ending March 2024 with a score of 3 out of 5. However, net sales were the highest in the last five quarters and cash and cash equivalents were at their highest in the last six periods, indicating potential for improvement.

GKB Ophthalmics, a microcap company in the FMCG industry, reported a flat performance for the quarter ending March 2024. Despite this, the company remains a strong player in the market with a wide range of ophthalmic products. MarketsMOJO has issued a 'Sell' call for the stock, but investors should conduct their own research before making any decisions.

GKB Ophthalmics, a microcap company in the FMCG industry, has seen a surge in its stock price, reaching a 52-week high on April 29th, 2024. Despite a Strong Sell rating from MarketsMOJO, the stock has consistently traded higher than its moving averages, indicating a positive trend. However, its 1-year return is slightly lower than the overall market's performance. Investors should conduct their own research before making any decisions.

GKB Ophthalmics, a microcap company in the FMCG industry, has recently experienced a decline in its stock price, hitting a 52-week low of Rs.74.1 on March 19, 2024. MarketsMOJO has given a Strong Sell recommendation for the stock. The stock has been underperforming and is currently trading below its moving averages.

GKB Ophthalmics, a microcap company in the FMCG industry, has recently hit a 52-week low on March 18, 2024. According to MarketsMOJO, the stock has been given a Strong Sell rating. It is currently trading below its moving averages and has shown a negative performance in the past year, indicating it has not kept up with the market trend. Investors are advised to do their own research before making any investment decisions.

GKB Ophthalmics, a microcap company in the FMCG industry, has seen a dip in its stock price, reaching a 52-week low of Rs 79.22 on March 13, 2024. The stock is currently trading below its moving averages and has underperformed the sector by -1.95%. In the past year, it has shown a negative return of -33.69%, highlighting its underperformance compared to the Sensex. Investors should monitor the stock closely as it continues to face downward pressure.

GKB Ophthalmics, a microcap company in the FMCG industry, has hit a 52-week low and received a Strong Sell rating from MarketsMOJO. The stock opened with a gain but quickly fell, showing high volatility and underperformance compared to the sector. In the past year, the company has struggled while the Sensex has shown growth.

GKB Ophthalmics, a microcap company in the FMCG industry, reported a decline in net sales, consolidated net profit, and operating profit for the quarter ended September 2023. MarketsMOJO has given a 'Strong Sell' rating for the stock, citing negative financial performance with a score of -12. However, the company has a high debtors turnover ratio, but its profit before and after tax have significantly decreased compared to previous quarters.